These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7655326)

  • 1. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension.
    Chow WH; McLaughlin JK; Mandel JS; Wacholder S; Niwa S; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):327-31. PubMed ID: 7655326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension.
    McLaughlin JK; Chow WH; Mandel JS; Mellemgaard A; McCredie M; Lindblad P; Schlehofer B; Pommer W; Niwa S; Adami HO
    Int J Cancer; 1995 Oct; 63(2):216-21. PubMed ID: 7591207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension, diuretics and breast cancer risk.
    Largent JA; McEligot AJ; Ziogas A; Reid C; Hess J; Leighton N; Peel D; Anton-Culver H
    J Hum Hypertens; 2006 Oct; 20(10):727-32. PubMed ID: 16885996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
    Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
    Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for renal cell cancer: the multiethnic cohort.
    Setiawan VW; Stram DO; Nomura AM; Kolonel LN; Henderson BE
    Am J Epidemiol; 2007 Oct; 166(8):932-40. PubMed ID: 17656615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, hypertension, and renal cancer.
    Yu MC; Ross RK
    N Engl J Med; 2001 Feb; 344(7):531-2. PubMed ID: 11221620
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive therapy and the risk of malignancies.
    Grossman E; Messerli FH; Goldbourt U
    Eur Heart J; 2001 Aug; 22(15):1343-52. PubMed ID: 11465967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
    Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
    Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet and risk of renal cell cancer: a population-based case-control study.
    Lindblad P; Wolk A; Bergström R; Adami HO
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):215-23. PubMed ID: 9107425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials.
    Hsu CY
    J Hum Hypertens; 2001 Feb; 15(2):99-106. PubMed ID: 11317188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Which optimal antihypertensive bitherapy for kidney patients?].
    Bonne JF; Shahapuni I; Mailliez S; Oprisiu R; Temmar M; Choukroun G; Massy ZA; Fournier A
    Nephrol Ther; 2007 Jun; 3(3):79-88. PubMed ID: 17540309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
    Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Rosenquist K
    Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.